Skip to main content
Echo

Subcategory / Daily archive

Healthcare news — September 1, 2026

Publications tagged with Healthcare published on September 1, 2026 (UTC). This is a fixed calendar-day archive.

3 publications

  1. WorldMiddle EastPublic HealthHealthcareGender

    Kazakhstan to Expand Medical Worker Insurance

    The Ministry of Health in Kazakhstan has proposed a draft decree to enhance insurance protection for healthcare workers. Key changes include expanding coverage to medical interns and residents, providing compensation for harm caused during training, and introducing a standard contract for insuring medical workers' lives and health while on duty. The project aims to increase social and legal protection for medical workers and improve patient protection mechanisms. The public discussion period ends on September 16, 2026.
    2 sourcesSee all sources
  2. SocietyPublic HealthHealthcareFraud

    Parents Refusing Vitamin K Injections Puts Newborns at Risk

    A concerning trend of parents refusing vitamin K injections for their newborns in the United States is leading to preventable cases of Vitamin K Deficiency Bleeding (VKDB), a rare but serious condition that can cause internal bleeding, brain damage, and death. The refusal rate has increased by 77% between 2017 and 2024, with unvaccinated newborns having an 81 times higher risk of developing VKDB. Medical professionals and lawmakers are alarmed by this trend and urge parents to follow the routine injection protocol to protect their babies.
    7 sourcesSee all sources
  3. SportsBudgetPublic HealthHealthcare

    Trump Administration's Drug Price Reforms Yield Historic Savings

    The Trump administration has secured the largest drop in prescription drug prices in over 60 years, with prices falling every month this year. The president's most-favored-nation policy and direct negotiations with pharmaceutical companies have led to landmark agreements, resulting in savings of over $600 billion. Americans can now shop for medications directly through TrumpRx, with some drugs seeing price cuts of up to 70%. Congress is urged to build on these gains by reining in pharmacy benefit managers.
    14 sourcesSee all sources